Literature DB >> 25496123

Low molecular weight heparin modulates maternal immune response in pregnant women and mice with thrombophilia.

Lydia Luley1, Anne Schumacher, Melissa J Mulla, Dirk Franke, Michael Löttge, Sara Fill Malfertheiner, Svetlana N Tchaikovski, Serban-Dan Costa, Berthold Hoppe, Vikki M Abrahams, Ana C Zenclussen.   

Abstract

PROBLEM: Thrombophilia is associated with pregnancy complications. Treatment with low molecular weight heparin (LMWH) improves pregnancy outcome, but the underlying mechanisms are not clear. METHODS OF STUDY: We analyzed Treg frequency in blood from thrombophilic pregnancies treated with LMWH (n = 32) or untreated (n = 33) and from healthy pregnancies (n = 39) at all trimesters. Additionally, we treated pregnant wild-type, heterozygous and homozygous factor-V-Leiden (FVL) mice with LMWH or PBS and determined Treg frequency, pro-/anti-inflammatory cytokine levels and Caspase-3-activity in placenta and decidua.
RESULTS: Treg frequencies were increased in second and third trimester in LMWH-treated thrombophilic pregnancies compared to controls. Treg levels were comparable to those of normal pregnancies. Homozygous FVL mice had decreased decidual Tregs compared to wild-type mice. LMWH treatment normalized Tregs and was associated with increased decidual IL-10 mRNA. LMWH diminished Caspase-3-activity in mice of all genotypes.
CONCLUSION: We demonstrated anti-apoptotic and anti-inflammatory effects of LMWH in pregnant FVL mice. LMWH increased Treg levels in mice and humans, which suggests benefits of LMWH treatment for thrombophilic women during pregnancy.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Apoptosis; low molecular weight heparin; pregnancy; regulatory T cell; thrombophilia

Mesh:

Substances:

Year:  2014        PMID: 25496123     DOI: 10.1111/aji.12348

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  9 in total

1.  Heparin affects the induction of regulatory T cells independent of anti-coagulant activity and suppresses allogeneic immune responses.

Authors:  Y Kashiwakura; H Kojima; Y Kanno; M Hashiguchi; T Kobata
Journal:  Clin Exp Immunol       Date:  2020-07-15       Impact factor: 4.330

2.  Preventive application of low molecular weight heparin ameliorates peripherally inserted central catheter-related venous thrombosis.

Authors:  Liquan Huang; Guiyuan Chen; Bo Hu; Shuxia Liang; Wenya Chu; Li Chen
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

Review 3.  Possible immunosuppressive effects of drug exposure and environmental and nutritional effects on infection and vaccination.

Authors:  H P Huemer
Journal:  Mediators Inflamm       Date:  2015-04-05       Impact factor: 4.711

4.  Effects of low molecular weight heparin on the polarization and cytokine profile of macrophages and T helper cells in vitro.

Authors:  Valentina Bruno; Judit Svensson-Arvelund; Marie Rubér; Göran Berg; Emilio Piccione; Maria C Jenmalm; Jan Ernerudh
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

5.  Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy.

Authors:  Michael Ian Jarman; Kevin Lee; Ariel Kanevsky; Sarah Min; Ilana Schlam; Chris Mahida; Ali Huda; Alexander Milgrom; Naila Goldenberg; Charles J Glueck; Ping Wang
Journal:  BMC Hematol       Date:  2017-03-27

6.  Efficacy of Low Molecular Heparin on Preeclampsia by Inhibiting Apoptosis of Trophoblasts via the p38MAPK Signaling Pathway.

Authors:  Dandan Quan; Li Li; Manzhen Zuo
Journal:  Comput Math Methods Med       Date:  2021-08-02       Impact factor: 2.238

7.  Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study.

Authors:  Wenxin Bai; Xinyang Zhang; Si Sun; Qiaohong Wang; Congcong Li; Xiaoxin Zhang; Aimin Zhao
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-07       Impact factor: 3.007

8.  Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature.

Authors:  E Papadakis; A Pouliakis; Α Aktypi; A Christoforidou; P Kotsi; G Αnagnostou; A Foifa; E Grouzi
Journal:  Thromb J       Date:  2019-12-04

9.  Role of low-molecular-weight heparin in altering uterine artery blood flow in recurrent spontaneous abortion: a prospective study.

Authors:  Kemei Zhang; Ensheng Wang; Yang Li; Haiyan Xu; Jiaou Zhang; Xuhong Wang; Jing Shu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.